Therefore, using a large, real-world population with type 2 diabetes, we constructed a model to assess the cost-effectiveness of widespread use of SGLT2is and GLP-1 RAs in people with type 2 diabetes, considering only major cardiovascular and kidney outcomes
Environ Toxicol Pharmacol 99:104093 Fathy MA, Alsemeh AE, Habib MA, Abdel-Nour HM, Hendawy DM, Eltaweel AM, Abdelkhalek A, Ahmed MM, Desouky MK, Hua J (2023) Liraglutide ameliorates diabetic-induced testicular dysfunction in male rats: role of GLP-1/Kiss1/GnRH and TGF-/Smad signaling pathways
ISBN 83-7432-095-8
Inhibition of A aggregates in Alzheimers disease by epigallocatechin and epicatechin-3-gallate from green tea
Hormones: Certain hormonal conditions can promote insulin resistance